Fulgent Genetics (FLGT) Profit After Tax (2015 - 2026)

Fulgent Genetics has disclosed Profit After Tax across 12 years of filings, most recently posting -$29.7 million for Q2 2026.

• In Q2 2026, Profit After Tax fell 54.34% year-over-year to -$29.7 million; the TTM figure through Jun 2026 stood at -$85.5 million (down 64.24% YoY), while the FY2025 annual figure was -$61.6 million, down 40.65% from the prior year.
• Profit After Tax came in at -$29.7 million for Q2 2026 at Fulgent Genetics, down from -$25.3 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $153.6 million in Q1 2022 to a low of -$134.3 million in Q4 2023.
• Average Profit After Tax over 5 years is -$10.7 million, with a median of -$13.7 million recorded in 2023.
• Year-over-year, Profit After Tax tumbled 883.36% in 2023 and surged 95.39% in 2024.
• Over 5 years, Profit After Tax stood at -$24.1 million in 2022, then slumped by 457.96% to -$134.3 million in 2023, then surged by 95.39% to -$6.2 million in 2024, then slumped by 282.07% to -$23.6 million in 2025, then fell by 25.66% to -$29.7 million in 2026.
• Per Business Quant data, the three most recent Profit After Tax figures were -$29.7 million in Q2 2026, -$25.3 million in Q1 2026, and -$23.6 million in Q4 2025.